1. Momenilandi, Mana, Lévy, Romain, Sobrino, Steicy, Casanova, Jean-Laurent, Béziat, Vivien. 2024. FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. In Cell, 187, 2817-2837.e31. doi:10.1016/j.cell.2024.04.009. https://pubmed.ncbi.nlm.nih.gov/38701783/
2. Cueto, Francisco J, Sancho, David. 2021. The Flt3L/Flt3 Axis in Dendritic Cell Biology and Cancer Immunotherapy. In Cancers, 13, . doi:10.3390/cancers13071525. https://pubmed.ncbi.nlm.nih.gov/33810248/
3. Cueto, Francisco J, Del Fresno, Carlos, Brandi, Paola, Krummel, Matthew F, Sancho, David. . DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells. In Journal for immunotherapy of cancer, 9, . doi:10.1136/jitc-2020-002054. https://pubmed.ncbi.nlm.nih.gov/33980589/
4. Faisal, Syed M, Mendez, Flor M, Nunez, Fernando, Castro, Maria G, Lowenstein, Pedro R. 2020. Immune-stimulatory (TK/Flt3L) gene therapy opens the door to a promising new treatment strategy against brainstem gliomas. In Oncotarget, 11, 4607-4612. doi:10.18632/oncotarget.27834. https://pubmed.ncbi.nlm.nih.gov/33400737/
5. Yao, Lun, Hu, Qiao, Chen, Siqi, Fan, Shengxian, He, Qigai. 2021. Recombinant Pseudorabies Virus with TK/gE Gene Deletion and Flt3L Co-Expression Enhances the Innate and Adaptive Immune Response via Activating Dendritic Cells. In Viruses, 13, . doi:10.3390/v13040691. https://pubmed.ncbi.nlm.nih.gov/33923590/
6. Umemura, Yoshie, Orringer, Daniel, Junck, Larry, Castro, Maria G, Lowenstein, Pedro R. . Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial. In The Lancet. Oncology, 24, 1042-1052. doi:10.1016/S1470-2045(23)00347-9. https://pubmed.ncbi.nlm.nih.gov/37657463/
7. Tiniakou, Ioanna, Hsu, Pei-Feng, Lopez-Zepeda, Lorena S, Mazzoni, Esteban O, Reizis, Boris. 2024. Genome-wide screening identifies Trim33 as an essential regulator of dendritic cell differentiation. In Science immunology, 9, eadi1023. doi:10.1126/sciimmunol.adi1023. https://pubmed.ncbi.nlm.nih.gov/38608038/